Communicating Pathologic Response Results in Resectable NSCLC
Project Oncology®Communicating Pathologic Response Results in Resectable NSCLC
Optimizing First-Line Care for PD-L1–Low Metastatic NSCLC
Project Oncology®Optimizing First-Line Care for PD-L1–Low Metastatic NSCLC
Managing Immune-Related Adverse Events in Metastatic NSCLC
Project Oncology®Managing Immune-Related Adverse Events in Metastatic NSCLC
Managing High-Risk Subgroups in Metastatic NSCLC
Project Oncology®Managing High-Risk Subgroups in Metastatic NSCLC
Interpreting Perioperative Trial Designs in Resectable NSCLC Research
Project Oncology®Interpreting Perioperative Trial Designs in Resectable NSCLC Research
Emerging Therapeutic Strategies in Metastatic NSCLC
Project Oncology®Emerging Therapeutic Strategies in Metastatic NSCLC
- advertisement
- 3 questions
- advertisement
Targeting Neutrophilic Inflammation in Bronchiectasis: An Emerging Approach
Medical Industry FeatureTargeting Neutrophilic Inflammation in Bronchiectasis: An Emerging Approach
Evaluating EFS and Surgical Outcomes in Resectable NSCLC: Insights From a Clinical Trial
Medical Industry FeatureEvaluating EFS and Surgical Outcomes in Resectable NSCLC: Insights From a Clinical Trial
Shared Decision-Making in Pulmonary Arterial Hypertension: Strategies for PAH Treatment Initiation and Support
Medical Industry FeatureShared Decision-Making in Pulmonary Arterial Hypertension: Strategies for PAH Treatment Initiation and Support
Immune Imprinting and Vaccines: Rethinking the First Exposure to Influenza
Medical Industry FeatureImmune Imprinting and Vaccines: Rethinking the First Exposure to Influenza
- Asthma CSI: Behind the Cytokine Curtain, Part 1: Asthma HQMedical Industry FeatureAsthma CSI: Behind the Cytokine Curtain, Part 1: Asthma HQ
- 05/29/2026
- 05/28/2026
- 05/28/2026
- 05/27/2026
- 05/25/2026
- 05/21/2026



















































